2024 Q2 Form 10-Q Financial Statement

#000175353924000063 Filed on May 09, 2024

View on sec.gov

Income Statement

Concept 2024 Q2 2024 Q1
Revenue $24.94M $24.24M
YoY Change 29.03% 31.74%
Cost Of Revenue $6.882M $7.033M
YoY Change -19.28% 8.57%
Gross Profit $18.06M $17.20M
YoY Change 67.17% 44.33%
Gross Profit Margin 72.4% 70.98%
Selling, General & Admin $18.21M $18.82M
YoY Change -2.95% -0.7%
% of Gross Profit 100.88% 109.38%
Research & Development $286.0K $456.0K
YoY Change 62.5% 111.11%
% of Gross Profit 1.58% 2.65%
Depreciation & Amortization $11.28M $11.18M
YoY Change -4.24% 15.84%
% of Gross Profit 62.46% 65.01%
Operating Expenses $18.50M $19.27M
YoY Change -2.34% 0.56%
Operating Profit -$11.72M -$13.25M
YoY Change -41.16% -21.58%
Interest Expense $3.029M $2.634M
YoY Change 35.1% 42.15%
% of Operating Profit
Other Income/Expense, Net $2.000K $1.000K
YoY Change -100.23% -100.11%
Pretax Income -$9.145M -$15.74M
YoY Change -72.64% -8.5%
Income Tax $252.0K $70.00K
% Of Pretax Income
Net Earnings -$9.397M -$15.81M
YoY Change -71.89% -8.69%
Net Earnings / Revenue -37.68% -65.23%
Basic Earnings Per Share -$0.06 -$0.11
Diluted Earnings Per Share -$0.06 -$0.11
COMMON SHARES
Basic Shares Outstanding 146.8M shares 146.3M shares
Diluted Shares Outstanding 145.2M shares 143.2M shares

Balance Sheet

Concept 2024 Q2 2024 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $41.23M $35.39M
YoY Change -28.51% -48.52%
Cash & Equivalents $25.55M $14.97M
Short-Term Investments $15.68M $20.43M
Other Short-Term Assets $4.833M $4.249M
YoY Change -11.37% -40.41%
Inventory
Prepaid Expenses
Receivables $8.218M $5.582M
Other Receivables $0.00 $0.00
Total Short-Term Assets $82.45M $69.36M
YoY Change 4.17% -24.11%
LONG-TERM ASSETS
Property, Plant & Equipment $52.48M $59.88M
YoY Change -35.69% -31.47%
Goodwill $9.393M $9.393M
YoY Change 0.0% 0.0%
Intangibles
YoY Change
Long-Term Investments $0.00
YoY Change -100.0%
Other Assets $2.963M $3.640M
YoY Change -9.44% 41.3%
Total Long-Term Assets $141.8M $140.8M
YoY Change -4.76% -6.08%
TOTAL ASSETS
Total Short-Term Assets $82.45M $69.36M
Total Long-Term Assets $141.8M $140.8M
Total Assets $224.3M $210.1M
YoY Change -1.66% -12.91%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $11.48M $13.08M
YoY Change 6.39% 23.72%
Accrued Expenses
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due $309.0K $304.0K
YoY Change
Total Short-Term Liabilities $19.68M $17.26M
YoY Change 13.41% -17.22%
LONG-TERM LIABILITIES
Long-Term Debt $108.3M $84.70M
YoY Change 36.34% 10.96%
Other Long-Term Liabilities $2.814M $4.041M
YoY Change -59.93% 5756.52%
Total Long-Term Liabilities $111.1M $88.74M
YoY Change 28.52% 16.15%
TOTAL LIABILITIES
Total Short-Term Liabilities $19.68M $17.26M
Total Long-Term Liabilities $111.1M $88.74M
Total Liabilities $147.8M $128.4M
YoY Change 5.89% 4.95%
SHAREHOLDERS EQUITY
Retained Earnings -$624.2M -$614.8M
YoY Change 4.75% 9.31%
Common Stock $15.00K $14.00K
YoY Change 7.14% 0.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $76.53M $81.71M
YoY Change
Total Liabilities & Shareholders Equity $224.3M $210.1M
YoY Change -1.66% -12.91%

Cashflow Statement

Concept 2024 Q2 2024 Q1
OPERATING ACTIVITIES
Net Income -$9.397M -$15.81M
YoY Change -71.89% -8.69%
Depreciation, Depletion And Amortization $11.28M $11.18M
YoY Change -4.24% 15.84%
Cash From Operating Activities -$1.792M -$3.810M
YoY Change -283.42% -77.05%
INVESTING ACTIVITIES
Capital Expenditures $3.279M $3.297M
YoY Change -41.15% 14.72%
Acquisitions
YoY Change
Other Investing Activities -$4.661M -$11.81M
YoY Change -59.82% -188.19%
Cash From Investing Activities -$7.940M -$15.11M
YoY Change -53.76% -243.64%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 21.00M $862.0K
YoY Change -3244.16% -97.01%
NET CHANGE
Cash From Operating Activities -1.792M -$3.810M
Cash From Investing Activities -7.940M -$15.11M
Cash From Financing Activities 21.00M $862.0K
Net Change In Cash 11.27M -$18.06M
YoY Change -166.83% -179.25%
FREE CASH FLOW
Cash From Operating Activities -$1.792M -$3.810M
Capital Expenditures $3.279M $3.297M
Free Cash Flow -$5.071M -$7.107M
YoY Change 10.36% -63.51%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2024Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
24236000 usd
CY2023Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
18397000 usd
CY2024Q1 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
18816000 usd
CY2023Q1 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
18949000 usd
CY2024Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
456000 usd
CY2023Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
216000 usd
CY2024Q1 us-gaap Depreciation And Amortization
DepreciationAndAmortization
11184000 usd
CY2023Q1 us-gaap Depreciation And Amortization
DepreciationAndAmortization
9655000 usd
CY2024Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-13253000 usd
CY2023Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-16901000 usd
CY2024Q1 us-gaap Gain Loss On Derivative Instruments Net Pretax
GainLossOnDerivativeInstrumentsNetPretax
-254000 usd
CY2023Q1 us-gaap Gain Loss On Derivative Instruments Net Pretax
GainLossOnDerivativeInstrumentsNetPretax
1531000 usd
CY2024Q1 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
0 usd
CY2023Q1 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
529000 usd
CY2024Q1 us-gaap Investment Income Interest
InvestmentIncomeInterest
400000 usd
CY2023Q1 us-gaap Investment Income Interest
InvestmentIncomeInterest
435000 usd
CY2024Q1 us-gaap Interest Expense
InterestExpense
2634000 usd
CY2023Q1 us-gaap Interest Expense
InterestExpense
1853000 usd
CY2024Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
1000 usd
CY2023Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-943000 usd
CY2024Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-15740000 usd
CY2023Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-17202000 usd
CY2024Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
70000 usd
CY2023Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
113000 usd
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
-15810000 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-17315000 usd
CY2024Q1 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
0 usd
CY2023Q1 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
0 usd
CY2024Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-15810000 usd
CY2023Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-17315000 usd
CY2024Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.11
CY2024Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.11
CY2023Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.14
CY2023Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.14
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
93159000 usd
CY2024Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
3488000 usd
CY2024Q1 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
1000 usd
CY2024Q1 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
1294000 usd
CY2024Q1 us-gaap Adjustments Related To Tax Withholding For Share Based Compensation
AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
419000 usd
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
-15810000 usd
CY2024Q1 us-gaap Stockholders Equity
StockholdersEquity
81713000 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
121874000 usd
CY2023Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
3214000 usd
CY2023Q1 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
3000 usd
CY2023Q1 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
11129000 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-17315000 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
118905000 usd
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
-15810000 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-17315000 usd
CY2024Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
11184000 usd
CY2023Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
9655000 usd
CY2024Q1 us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
191000 usd
CY2023Q1 us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
446000 usd
CY2024Q1 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
100000 usd
CY2023Q1 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
0 usd
CY2024Q1 us-gaap Share Based Compensation
ShareBasedCompensation
3363000 usd
CY2023Q1 us-gaap Share Based Compensation
ShareBasedCompensation
3012000 usd
CY2024Q1 us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
2121000 usd
CY2023Q1 us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
113000 usd
CY2024Q1 us-gaap Unrealized Gain Loss On Derivatives
UnrealizedGainLossOnDerivatives
-254000 usd
CY2023Q1 us-gaap Unrealized Gain Loss On Derivatives
UnrealizedGainLossOnDerivatives
1531000 usd
CY2024Q1 us-gaap Interest Income Operating
InterestIncomeOperating
267000 usd
CY2023Q1 us-gaap Interest Income Operating
InterestIncomeOperating
156000 usd
CY2024Q1 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
0 usd
CY2023Q1 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
529000 usd
CY2024Q1 us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
0 usd
CY2023Q1 us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
22000 usd
CY2024Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-1388000 usd
CY2023Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
5947000 usd
CY2024Q1 us-gaap Increase Decrease In Contract With Customer Asset
IncreaseDecreaseInContractWithCustomerAsset
3328000 usd
CY2023Q1 us-gaap Increase Decrease In Contract With Customer Asset
IncreaseDecreaseInContractWithCustomerAsset
591000 usd
CY2024Q1 us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
195000 usd
CY2023Q1 us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
-462000 usd
CY2024Q1 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
-344000 usd
CY2023Q1 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
8000 usd
CY2024Q1 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-2354000 usd
CY2023Q1 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-2966000 usd
CY2024Q1 us-gaap Increase Decrease In Other Current Liabilities
IncreaseDecreaseInOtherCurrentLiabilities
447000 usd
CY2023Q1 us-gaap Increase Decrease In Other Current Liabilities
IncreaseDecreaseInOtherCurrentLiabilities
1732000 usd
CY2024Q1 us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
-1239000 usd
CY2023Q1 us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
-2951000 usd
CY2024Q1 us-gaap Increase Decrease In Other Noncurrent Liabilities
IncreaseDecreaseInOtherNoncurrentLiabilities
-9000 usd
CY2023Q1 us-gaap Increase Decrease In Other Noncurrent Liabilities
IncreaseDecreaseInOtherNoncurrentLiabilities
-6000 usd
CY2024Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-3810000 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-16602000 usd
CY2024Q1 us-gaap Payments To Acquire Other Property Plant And Equipment
PaymentsToAcquireOtherPropertyPlantAndEquipment
3297000 usd
CY2023Q1 us-gaap Payments To Acquire Other Property Plant And Equipment
PaymentsToAcquireOtherPropertyPlantAndEquipment
2874000 usd
CY2024Q1 bksy Satellite Procurement Work In Process
SatelliteProcurementWorkInProcess
11347000 usd
CY2023Q1 bksy Satellite Procurement Work In Process
SatelliteProcurementWorkInProcess
12926000 usd
CY2024Q1 us-gaap Payments To Acquire Short Term Investments
PaymentsToAcquireShortTermInvestments
9464000 usd
CY2023Q1 us-gaap Payments To Acquire Short Term Investments
PaymentsToAcquireShortTermInvestments
11792000 usd
CY2024Q1 us-gaap Proceeds From Sale Of Short Term Investments
ProceedsFromSaleOfShortTermInvestments
9000000 usd
CY2023Q1 us-gaap Proceeds From Sale Of Short Term Investments
ProceedsFromSaleOfShortTermInvestments
38110000 usd
CY2024Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-15108000 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
10518000 usd
CY2024Q1 bksy Proceeds From Private Placement Net Of Equity Issuance Costs
ProceedsFromPrivatePlacementNetOfEquityIssuanceCosts
1298000 usd
CY2023Q1 bksy Proceeds From Private Placement Net Of Equity Issuance Costs
ProceedsFromPrivatePlacementNetOfEquityIssuanceCosts
29432000 usd
CY2024Q1 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
1000 usd
CY2023Q1 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
3000 usd
CY2024Q1 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
419000 usd
CY2023Q1 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
0 usd
CY2024Q1 us-gaap Payments Of Financing Costs
PaymentsOfFinancingCosts
18000 usd
CY2023Q1 us-gaap Payments Of Financing Costs
PaymentsOfFinancingCosts
0 usd
CY2024Q1 bksy Payments For Deferred Offering Costs
PaymentsForDeferredOfferingCosts
0 usd
CY2023Q1 bksy Payments For Deferred Offering Costs
PaymentsForDeferredOfferingCosts
-552000 usd
CY2024Q1 us-gaap Payments Of Derivative Issuance Costs
PaymentsOfDerivativeIssuanceCosts
0 usd
CY2023Q1 us-gaap Payments Of Derivative Issuance Costs
PaymentsOfDerivativeIssuanceCosts
16000 usd
CY2024Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
862000 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
28867000 usd
CY2024Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-18056000 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
22783000 usd
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
33434000 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
37016000 usd
CY2024Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
15378000 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
59799000 usd
CY2024Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
14965000 usd
CY2023Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
56964000 usd
CY2024Q1 us-gaap Restricted Cash
RestrictedCash
413000 usd
CY2023Q1 us-gaap Restricted Cash
RestrictedCash
2835000 usd
CY2024Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
15378000 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
59799000 usd
CY2024Q1 us-gaap Interest Paid Net
InterestPaidNet
0 usd
CY2023Q1 us-gaap Interest Paid Net
InterestPaidNet
0 usd
CY2024Q1 us-gaap Income Taxes Paid
IncomeTaxesPaid
0 usd
CY2023Q1 us-gaap Income Taxes Paid
IncomeTaxesPaid
0 usd
CY2024Q1 bksy Vendor Financed Satellite Procurement Costs
VendorFinancedSatelliteProcurementCosts
1500000 usd
CY2023Q1 bksy Vendor Financed Satellite Procurement Costs
VendorFinancedSatelliteProcurementCosts
0 usd
CY2024Q1 bksy Credits From Leo Stella Applied To Satellite Procurement Costs
CreditsFromLeoStellaAppliedToSatelliteProcurementCosts
966000 usd
CY2023Q1 bksy Credits From Leo Stella Applied To Satellite Procurement Costs
CreditsFromLeoStellaAppliedToSatelliteProcurementCosts
0 usd
CY2024Q1 bksy Leasehold Improvements Funded By Tenant Improvement Allowance
LeaseholdImprovementsFundedByTenantImprovementAllowance
586000 usd
CY2023Q1 bksy Leasehold Improvements Funded By Tenant Improvement Allowance
LeaseholdImprovementsFundedByTenantImprovementAllowance
0 usd
CY2024Q1 us-gaap Accretion Amortization Of Discounts And Premiums Investments
AccretionAmortizationOfDiscountsAndPremiumsInvestments
267000 usd
CY2023Q1 us-gaap Accretion Amortization Of Discounts And Premiums Investments
AccretionAmortizationOfDiscountsAndPremiumsInvestments
156000 usd
CY2024Q1 bksy Capitalized Stock Based Compensation
CapitalizedStockBasedCompensation
125000 usd
CY2023Q1 bksy Capitalized Stock Based Compensation
CapitalizedStockBasedCompensation
202000 usd
CY2024Q1 bksy Deferred Financing Costs Accrued But Not Yet Paid
DeferredFinancingCostsAccruedButNotYetPaid
97000 usd
CY2023Q1 bksy Deferred Financing Costs Accrued But Not Yet Paid
DeferredFinancingCostsAccruedButNotYetPaid
0 usd
CY2024Q1 bksy Equity Costs Accrued But Not Paid
EquityCostsAccruedButNotPaid
17000 usd
CY2023Q1 bksy Equity Costs Accrued But Not Paid
EquityCostsAccruedButNotPaid
588000 usd
CY2024Q1 bksy Transaction Costs Related To Derivative Liabilities Accrued But Not Paid
TransactionCostsRelatedToDerivativeLiabilitiesAccruedButNotPaid
0 usd
CY2023Q1 bksy Transaction Costs Related To Derivative Liabilities Accrued But Not Paid
TransactionCostsRelatedToDerivativeLiabilitiesAccruedButNotPaid
888000 usd
CY2024Q1 us-gaap Interest Costs Capitalized
InterestCostsCapitalized
0 usd
CY2023Q1 us-gaap Interest Costs Capitalized
InterestCostsCapitalized
220000 usd
CY2024Q1 bksy Settlement Costs
SettlementCosts
0 usd
CY2023Q1 bksy Settlement Costs
SettlementCosts
36000 usd
CY2024Q1 bksy Deferred Offering Costs Accrued But Not Paid
DeferredOfferingCostsAccruedButNotPaid
0 usd
CY2023Q1 bksy Deferred Offering Costs Accrued But Not Paid
DeferredOfferingCostsAccruedButNotPaid
31000 usd
CY2024Q1 bksy Proceeds From Sale Of Property And Equipment Accrued But Not Received
ProceedsFromSaleOfPropertyAndEquipmentAccruedButNotReceived
0 usd
CY2023Q1 bksy Proceeds From Sale Of Property And Equipment Accrued But Not Received
ProceedsFromSaleOfPropertyAndEquipmentAccruedButNotReceived
24000 usd
CY2024Q1 bksy Number Of Subsidiaries
NumberOfSubsidiaries
2 satellite
CY2024Q1 us-gaap Proceeds From Issuance Of Private Placement
ProceedsFromIssuanceOfPrivatePlacement
1400000 usd
CY2024Q1 bksy Private Placement Transaction Costs
PrivatePlacementTransactionCosts
79000 usd
CY2024Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
24236000 usd
CY2023Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
18397000 usd
CY2024Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
24236000 usd
CY2023Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
18397000 usd
CY2024Q1 us-gaap Use Of Estimates
UseOfEstimates
<div style="margin-bottom:6pt;padding-left:18pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Use of Estimates</span></div><div style="margin-bottom:6pt;padding-left:18pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of the unaudited condensed consolidated financial statements requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, the disclosure of </span></div><div style="margin-bottom:6pt;padding-left:18pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">contingencies at the reporting date, and the reported amounts of revenue and expenses during the reporting period. These estimates are based on management’s best knowledge of current events and actions the Company may undertake in the future. Actual results could materially differ from these estimates. Significant estimates made by the Company include, but are not limited to, revenue and associated cost recognition, the collectability of accounts receivable, the recoverability and useful lives of property and equipment, the valuation of equity warrants and warrant liabilities, fair value estimates, the recoverability of goodwill and intangible assets, the provision for income taxes, the incremental borrowing rate to measure the operating lease right of use assets, and stock-based compensation.</span></div>
CY2024Q1 us-gaap Held To Maturity Securities Current
HeldToMaturitySecuritiesCurrent
20400000 usd
CY2023Q4 us-gaap Held To Maturity Securities Current
HeldToMaturitySecuritiesCurrent
19700000 usd
CY2024Q1 us-gaap Held To Maturity Securities Fair Value
HeldToMaturitySecuritiesFairValue
20400000 usd
CY2023Q4 us-gaap Held To Maturity Securities Fair Value
HeldToMaturitySecuritiesFairValue
19700000 usd
CY2023Q4 us-gaap Equity Method Investments
EquityMethodInvestments
0 usd
CY2024Q1 us-gaap Basic Earnings Per Share Adjustment Pro Forma
BasicEarningsPerShareAdjustmentProForma
-0.00
CY2024Q1 us-gaap Earnings Per Share Diluted Pro Forma Adjustment
EarningsPerShareDilutedProFormaAdjustment
-0.00
CY2023Q1 us-gaap Earnings Per Share Diluted Pro Forma Adjustment
EarningsPerShareDilutedProFormaAdjustment
-0.00
CY2023Q1 us-gaap Basic Earnings Per Share Adjustment Pro Forma
BasicEarningsPerShareAdjustmentProForma
-0.00
CY2024Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
24236000 usd
CY2023Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
18397000 usd
CY2024Q1 bksy Revenue Remaining Performance Obligation Amount1
RevenueRemainingPerformanceObligationAmount1
244800000 usd
CY2024Q1 us-gaap Unbilled Receivables Current
UnbilledReceivablesCurrent
24134000 usd
CY2023Q4 us-gaap Unbilled Receivables Current
UnbilledReceivablesCurrent
15213000 usd
CY2024Q1 us-gaap Contract With Customer Asset Net Current
ContractWithCustomerAssetNetCurrent
24134000 usd
CY2023Q4 us-gaap Contract With Customer Asset Net Current
ContractWithCustomerAssetNetCurrent
15213000 usd
CY2024Q1 bksy Unbilled Revenue Long Term
UnbilledRevenueLongTerm
2607000 usd
CY2023Q4 bksy Unbilled Revenue Long Term
UnbilledRevenueLongTerm
8150000 usd
CY2024Q1 bksy Other Contract With Customer Asset After Allowance For Credit Loss Noncurrent
OtherContractWithCustomerAssetAfterAllowanceForCreditLossNoncurrent
560000 usd
CY2023Q4 bksy Other Contract With Customer Asset After Allowance For Credit Loss Noncurrent
OtherContractWithCustomerAssetAfterAllowanceForCreditLossNoncurrent
610000 usd
CY2024Q1 us-gaap Contract With Customer Asset Net Noncurrent
ContractWithCustomerAssetNetNoncurrent
3167000 usd
CY2023Q4 us-gaap Contract With Customer Asset Net Noncurrent
ContractWithCustomerAssetNetNoncurrent
8760000 usd
CY2024Q1 bksy Contract With Customer Liability Current1
ContractWithCustomerLiabilityCurrent1
2157000 usd
CY2023Q4 bksy Contract With Customer Liability Current1
ContractWithCustomerLiabilityCurrent1
3670000 usd
CY2024Q1 bksy Contract With Customer Liability Noncurrent1
ContractWithCustomerLiabilityNoncurrent1
443000 usd
CY2023Q4 bksy Contract With Customer Liability Noncurrent1
ContractWithCustomerLiabilityNoncurrent1
169000 usd
CY2023Q4 us-gaap Contract With Customer Asset Net
ContractWithCustomerAssetNet
23973000 usd
CY2023Q4 bksy Contract With Customer Liability1
ContractWithCustomerLiability1
3839000 usd
CY2024Q1 us-gaap Contract With Customer Asset Reclassified To Receivable
ContractWithCustomerAssetReclassifiedToReceivable
-3356000 usd
CY2024Q1 us-gaap Contract With Customer Liability Change In Timeframe Performance Obligation Satisfied Revenue Recognized
ContractWithCustomerLiabilityChangeInTimeframePerformanceObligationSatisfiedRevenueRecognized
2897000 usd
CY2024Q1 bksy Contract With Customer Asset Changes In Contract Assets Net
ContractWithCustomerAssetChangesInContractAssetsNet
6930000 usd
CY2024Q1 bksy Contract With Customer Liability Revenue Recognized1
ContractWithCustomerLiabilityRevenueRecognized1
-1319000 usd
CY2024Q1 us-gaap Contract With Customer Asset Cumulative Catch Up Adjustment To Revenue Change In Estimate Of Transaction Price
ContractWithCustomerAssetCumulativeCatchUpAdjustmentToRevenueChangeInEstimateOfTransactionPrice
196000 usd
CY2024Q1 us-gaap Contract With Customer Liability Cumulative Catch Up Adjustment To Revenue Change In Estimate Of Transaction Price
ContractWithCustomerLiabilityCumulativeCatchUpAdjustmentToRevenueChangeInEstimateOfTransactionPrice
65000 usd
CY2024Q1 bksy Contract With Customer Asset Changes Of Contract Costs
ContractWithCustomerAssetChangesOfContractCosts
50000 usd
CY2024Q1 bksy Contract With Customer Liability Changes Of Contract Liabilities
ContractWithCustomerLiabilityChangesOfContractLiabilities
274000 usd
CY2024Q1 us-gaap Contract With Customer Asset Net
ContractWithCustomerAssetNet
27301000 usd
CY2024Q1 bksy Contract With Customer Liability1
ContractWithCustomerLiability1
2600000 usd
CY2024Q1 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
152136000 usd
CY2023Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
157230000 usd
CY2024Q1 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
92253000 usd
CY2023Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
90114000 usd
CY2024Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
59883000 usd
CY2023Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
67116000 usd
CY2024Q1 bksy Long Term Debt Gross Current
LongTermDebtGrossCurrent
375000 usd
CY2023Q4 bksy Long Term Debt Gross Current
LongTermDebtGrossCurrent
0 usd
CY2024Q1 bksy Long Term Debt Gross Noncurrent
LongTermDebtGrossNoncurrent
85703000 usd
CY2024Q1 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
86078000 usd
CY2023Q4 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
84578000 usd
CY2024Q1 us-gaap Debt Instrument Unamortized Discount Premium And Debt Issuance Costs Net
DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet
1079000 usd
CY2023Q4 us-gaap Debt Instrument Unamortized Discount Premium And Debt Issuance Costs Net
DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet
1076000 usd
CY2024Q1 us-gaap Long Term Debt
LongTermDebt
84999000 usd
CY2023Q4 us-gaap Long Term Debt
LongTermDebt
83502000 usd
CY2024Q1 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
86078000 usd
CY2023Q4 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
84578000 usd
CY2023Q4 bksy Satellite Procurement Vendor Financing Amount
SatelliteProcurementVendorFinancingAmount
27000000 usd
CY2024Q1 us-gaap Long Term Debt Fair Value
LongTermDebtFairValue
91000000 usd
CY2023Q4 us-gaap Long Term Debt Fair Value
LongTermDebtFairValue
78700000 usd
CY2024Q1 us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
0 usd
CY2023Q1 us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
905000 usd
CY2024Q1 bksy Other Income Expense
OtherIncomeExpense
-1000 usd
CY2023Q1 bksy Other Income Expense
OtherIncomeExpense
38000 usd
CY2024Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
1000 usd
CY2023Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-943000 usd
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
-15810000 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-17315000 usd
CY2024Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.11
CY2024Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.11
CY2023Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.14
CY2023Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.14
CY2024Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
143228000 shares
CY2024Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
143228000 shares
CY2023Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
124144000 shares
CY2023Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
124144000 shares
CY2024Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
3363000 usd
CY2023Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
3012000 usd
CY2024Q1 bksy Capitalized Stock Based Compensation
CapitalizedStockBasedCompensation
100000 usd
CY2023Q1 bksy Capitalized Stock Based Compensation
CapitalizedStockBasedCompensation
200000 usd
CY2023Q4 us-gaap Deposit Liabilities Accrued Interest
DepositLiabilitiesAccruedInterest
1700000 usd
CY2024Q1 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
3700000 usd
CY2024Q1 ecd Non Rule10b51 Arr Adopted Flag
NonRule10b51ArrAdoptedFlag
false
CY2024Q1 ecd Rule10b51 Arr Adopted Flag
Rule10b51ArrAdoptedFlag
false
CY2024Q1 ecd Non Rule10b51 Arr Trmntd Flag
NonRule10b51ArrTrmntdFlag
false
CY2024Q1 ecd Rule10b51 Arr Trmntd Flag
Rule10b51ArrTrmntdFlag
false

Files In Submission

Name View Source Status
0001753539-24-000063-index-headers.html Edgar Link pending
0001753539-24-000063-index.html Edgar Link pending
0001753539-24-000063.txt Edgar Link pending
0001753539-24-000063-xbrl.zip Edgar Link pending
bksy-20240331.htm Edgar Link pending
bksy-20240331.xsd Edgar Link pending
blackskyexhibit311march2024.htm Edgar Link pending
blackskyexhibit312march2024.htm Edgar Link pending
blackskyexhibit321march2024.htm Edgar Link pending
blackskyexhibit322march2024.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
bksy-20240331_def.xml Edgar Link unprocessable
bksy-20240331_lab.xml Edgar Link unprocessable
bksy-20240331_pre.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
bksy-20240331_htm.xml Edgar Link completed
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
bksy-20240331_cal.xml Edgar Link unprocessable